Abstract
Reactions of diol epoxide metabolites of carcinogenic poly cyclic aromatic hydrocarbons with DNA are thought to initiate the carcinogenic process1,2. Although formation of a benzo[a]pyrene (BaP) diol epoxide-deoxyguanosine adduct has been held responsible for biological activity3–5, the more potent carcinogen, 7,12-dimethylbenz[a]anthracene (DMBA) binds extensively to deoxyadenosine residues in DNA, suggesting that hydrocarbon carcinogen-deoxyadenosine adducts may be instrumental in tumour initiation6–8. Because the bay region diol epoxides9 of benzo[c]phenanthrene (BcPh) are very active tumour initiators10, and the relative activities of the four configurationally isomeric 3,4-diol 1,2-e pox ides (Fig. 1) are known11, we examined their reactions with DNA. Each BcPh diol epoxide isomer exhibits a remarkable preference for covalent binding to DNA over hydrolysis, each yields a unique distribution of products with the nucleosides of DNA and each reacts extensively with deoxyadenosine residues in DNA. The relative tumour initiating activities of these stereoisomers is best reflected by the relative yields of one of the deoxyadenosine adducts formed.
Similar content being viewed by others
References
1. Sims, P., Grover, P. L., Swaisland, A., Pal, K. & Hewer, A. Nature 252, 326–328 (1974). 2. Buening, M. K. et al. Proc. natn. Acad. Sci. U.S.A. 75, 5358–5361 (1978). 3. Meehan, T., Straub, K. & Calvin, M. Nature 269, 725–727 (1977). 4. Ashurst, S. W. & Cohen, G. M. Chem. Biol. Interact. 29, 117–127 (1980). 5. Lo, K–y & Kakunaga, T. Biochem. biophys. Res. Commun. 99, 820–829 (1981). 6. Dipple, A., Pigott, M. A., Moschel, R. C. & Costantino, A. Cancer Res. 43,4132–4135 (1983). 7. Dipple, A., Sawicki, J. T., Moschel, R. C. & Bigger, C. A. H. in Extrahepatic Drug Metabolism and Chemical Carcinogenesis (eds Rydstrom, J., Montelius, J. & Bengtsson, M.) 439–448 (Elsevier, Amsterdam, 1983). 8. Bigger, C. A. H., Sawicki, J. T., Blake, D. M., Raymond, L. G. & Dipple, A. Cancer Res. 43, 5647–5651 (1983). 9. Jerina, D. M. & Daly, J. W. in Drug Metabolism (eds Parke, D. V. & Smith, R. L.) 13–32 (Taylor & Francis, London, 1976). 10. Levin, W. et al. Cancer Res. 40, 3910–3914 (1980). 11. Levin, W. et al. Cancer Res. 46, 2257–2261 (1986). 12. Jerina, D. M. et al. in Biological Reactive Intermediates III (eds Snyder, R., Kocsis, J. J., Jollow, D. J. & Witmer, C. M.) 11–30 (Plenum, New York, 1986). 13. Moussaoui, K., Geacintov, N. E. & Harvey, R. G. Biophys. Chem. 22, 285–297 (1985). 14. Agarwal, S. K. et al. J. Am. chem. Soc. 109, 2497–2504 (1987). 15. Zacharias, D. E. et al. Carcinogenesis 5, 1421–1430 (1984). 16. Hirshfeld, F. L. /. chem. Soc. 2126–2135 (1963). 17. Zarbl, H., Sukumar, S., Arthur, A. V., Martin–Zanca, D. & Barbacid, M. Nature 315,382–385 (1985). 18. Quintanilla, M., Brown, K., Ramsden, M. & Balamain, A. Nature 322, 78–80 (1986). 19. Dandekar, S., Sukumar, S., Zarbl, H., Young, L. J. T. & Cardiff, R. D. Molec. cell. Biol. 6, 4104–4108 (1986). 20. Vousden, K. H., Bos, J. L., Marshall, C. J. & Phillips, D. H. Proc. natn. Acad. Sci. U.S.A. 83, 1222–1226 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dipple, A., Pigott, M., Agarwal, S. et al. Optically active benzo[c]phenanthrene diol epoxides bind extensively to adenine in DNA. Nature 327, 535–536 (1987). https://doi.org/10.1038/327535a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/327535a0
- Springer Nature Limited